###begin article-title 0
###xml 111 114 <span type="species:ncbi:9606">Men</span>
Association between Bone Mineral Density and LDL Receptor-Related Protein 5 Gene Polymorphisms in Young Korean Men
###end article-title 0
###begin p 1
###xml 776 777 776 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 942 943 942 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1013 1014 1013 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1259 1263 1259 1263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5</italic>
###xml 344 347 <span type="species:ncbi:9606">men</span>
###xml 1305 1308 <span type="species:ncbi:9606">men</span>
Recently, It has been reported that the LDL receptor-related protein 5 (LRP5) regulates bone formation, and that mutations of the gene cause osteoporosis-pseudoglioma syndrome or high bone mass phenotypes. However, the mutations cannot explain a genetic trait for osteoporosis in the general population because of their rarity. From 219 Korean men aged 20-34 yr, we looked for six known polymorphisms causing amino acid changes in the LRP5 coding region, and investigated their association with bone mineral density (BMD) at the following anatomical sites: lumbar spine (L2-L4) and the left proximal femur (femoral neck, Ward's triangle, trochanter and shaft). We found that the Q89R polymorphism was significantly associated with BMD at the femoral neck and Ward's triangle (p=0.004 and <0.001, respectively). However, after adjusting for age, weight and height, a statistically significant association only occurred at the Ward's triangle (p=0.043), and a marginal association was observed at the femoral neck (p=0.098). No A400V, V667M, R1036Q and A1525V polymorphisms were found, and no statistically significant association was found between the A1330V polymorphism and BMD at any sites. Although we failed to demonstrate a clear association between the LRP5 polymorphism and peak bone mass in young men, the present study suggests that larger-scale studies on the Q89R polymorphism need to be performed.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 193 194 193 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 306 307 306 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 454 455 454 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 78 83 <span type="species:ncbi:9606">women</span>
###xml 109 112 <span type="species:ncbi:9606">men</span>
###xml 157 160 <span type="species:ncbi:9606">men</span>
###xml 186 191 <span type="species:ncbi:9606">women</span>
###xml 264 267 <span type="species:ncbi:9606">men</span>
###xml 299 304 <span type="species:ncbi:9606">women</span>
###xml 447 452 <span type="species:ncbi:9606">women</span>
Although osteoporosis is more generally considered as a disease that afflicts women, it is also prevalent in men. The incidence of osteoporotic fractures in men is about half of that in women (1). Furthermore, the mortality associated with hip fracture in elderly men is considerably higher than in women (2). However, the cellular and molecular basis underlying male osteoporosis is still poorly understood due to the emphasis on osteoporosis in women (3).
###end p 3
###begin p 4
###xml 96 97 96 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 256 257 256 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 490 491 490 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 558 559 558 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 377 382 <span type="species:ncbi:9606">women</span>
###xml 513 516 <span type="species:ncbi:9606">men</span>
Peak bone mass, which is recognized as an important determinant in development of osteoporosis (4), is under strong genetic control, and genetic influences have been estimated to account for about 75% of the inter-individual variability in peak bone mass (5). Although many genes have been examined for their association with bone mass, most studies were carried out in either women or populations of older subjects of an age when accretion of bone mass has ceased and bone loss has begun (6). Genetic studies in men with peak bone mass are relatively rare (3).
###end p 4
###begin p 5
###xml 117 118 117 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 120 121 120 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 158 162 158 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5</italic>
###xml 312 313 312 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 480 481 480 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 532 536 532 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5</italic>
###xml 709 710 709 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 712 714 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
LDL receptor-related protein 5 (LRP5) has emerged as a key regulator of osteoblast proliferation and bone formation (7, 8). Loss-of-function mutations of the LRP5 gene cause the autosomal recessive osteoporosis pseudoglioma syndrome (OPPG), a disorder causing both congenital osteoporosis and eye abnormalities (7), while autosomal dominant high bone mass (HBM) traits result from a gain-of-function mutation of the gene that causes a glycine-to-valine amino acid change (G171V) (9-11). Collectively, these studies suggest that the LRP5 gene is an important regulator of peak bone mass in vertebrates, although genetic mutations causing OPPG syndrome or HBM phenotype are very rare in the general population (7, 11).
###end p 5
###begin p 6
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5</italic>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 228 232 228 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5</italic>
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 398 400 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 541 545 541 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5</italic>
###xml 631 633 631 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 635 637 635 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 684 688 684 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5</italic>
It has been suggested that a common polymorphism in the LRP5 gene might contribute to genetic variations in bone mass in the general community (12). Torus palatinus, which was observed in subjects with the G171V mutation of the LRP5 gene, is commonly detected in the general population (13, 14), and this was reported to serve as a physical marker of high bone mineral density (BMD) in Caucasians (13) and Japanese (15). More importantly, several quantitative trait locus (QTL) analyses reported that the region 11q12-13, which contains the LRP5 gene, strongly contributes to the normal variation of BMD in the general population (16, 17). However, there is no information on whether LRP5 polymorphisms are associated with BMD in the general community.
###end p 6
###begin p 7
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 225 228 <span type="species:ncbi:9606">men</span>
Recently, two mutation analyses reported seven and forty-two LRP5 gene polymorphisms in Japanese (18) and Caucasians (19), respectively. In the present study, we examined LRP5 gene coding region polymorphisms in young Korean men. We determined the frequency of occurrence of six polymorphisms causing amino acid changes, and investigated whether these polymorphisms were associated with BMD.
###end p 7
###begin title 8
MATERIALS AND METHODS
###end title 8
###begin title 9
Subjects
###end title 9
###begin p 10
###xml 662 664 662 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 666 668 666 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 49 52 <span type="species:ncbi:9606">men</span>
The study population comprised 219 healthy young men who were medical students of University of Ulsan or residents at a university hospital (Asan Medical Center (AMC)) in Seoul, Korea. All subjects were Korean and volunteered for the study. The study was approved by the AMC ethics review committee and written informed consent was obtained from all subjects. Subjects completed a self-administered questionnaire concerning demographic characteristics, general health status, medication, weekly duration of weight-bearing physical activity, and smoking and alcohol drinking habits. Daily dietary calcium intake was assessed using a food frequency questionnaire (20, 21). All subjects were free from drugs and diseases known to affect bone metabolism.
###end p 10
###begin title 11
Bone mineral densitometry
###end title 11
###begin p 12
###xml 13 14 13 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
All BMD (g/cm2) measurements of the lumbar spine (L2-L4, A-P) and the left proximal femur (femoral neck, Ward's triangle, trochanter and shaft) were measured by the same trained technician using a Lunar Corp. Expert XL (Lunar, Madison, WI, U.S.A.) dual energy radiography absorptiometer (software version 1.90). The in vivo precision of the machine was 0.82% for the lumbar spine, 1.12% for the femoral neck and 2.17% for Ward's triangle.
###end p 12
###begin title 13
Genotype analysis with polymerase chain reaction and restriction fragment length polymorphism analysis
###end title 13
###begin p 14
###xml 386 388 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 626 628 626 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 710 713 710 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ava</italic>
###xml 720 723 720 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dra</italic>
Genomic DNA was extracted from peripheral blood leukocytes using a commercial kit (Wizard Genomic DNA purification kit, Promega, Madison, WI, U.S.A.). Genotyping of DNA sequence variants in the Q89R and A1330V sites was carried out by restriction enzyme analysis of polymerase chain reaction (PCR)-amplified DNA using specific pairs of oligonucleotide primers, as described previously (18). The PCR primers were sequence-specific and/or mutated for convenience. Amplification of polymorphisms was carried out using a thermocycler (Perkin-Elmer, Boston, MA, U.S.A.) using a method described previously with some modifications (18). After amplification, PCR products were digested with restriction endonucleases AvaII and DraIII (New England Biolabs Inc., Beverly, MA, U.S.A.) for the Q89R and A1330V polymorphisms, respectively. The DNA fragments were then electrophoresed on 2% and 3% agarose gels for the Q89R and A1330V polymorphisms, respectively.
###end p 14
###begin p 15
###xml 297 299 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 920 927 884 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 1719 1721 1656 1658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 1790 1797 1727 1734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
Because previously reported restriction enzyme analyses of polymerase chain reaction (PCR) were not available, genotyping for A400V, V667M, R1036Q and A1525V polymorphisms was performed by SNP-ITtrade mark assays using the SNP stream 25Ktrade mark System (Orchid Biosciences, New Jersey, U.S.A.) (22). Briefly, the genomic DNA region spanning the polymorphic site was PCR-amplified using one phosphothiolated primer and one regular PCR primer. The amplified PCR products were then digested with exonuclease, with the 5' phosphothiolates protecting one strand of the PCR product from digestion. The single-strand PCR template generated by exonuclease digestion was overlaid onto a 384-well plate that was precoated covalently with the primer extension SNP-ITtrade mark primers. These SNP-ITtrade mark primers were designed to hybridize immediately adjacent to the polymorphic site. The PCR primer sequences are listed in Table 1. After hybridization of template strands, SNP-ITtrade mark primers were then extended by a single base with DNA polymerase at the polymorphic site of interest. The extension mixtures contained two labeled terminating nucleotides (one FITC, one biotin) and two unlabeled terminating nucleotides. The final single base incorporated was identified with serial colorimetric reactions with anti-FITC-AP or streptavidin-HRP. The results of blue and/or yellow color developments were analyzed using an ELISA reader, and the final genotyping (allele) calls were made using the QCReviewtrade mark program. To confirm polymorphisms identified using SNP-ITtrade mark assays, direct DNA sequencing was performed on 20 samples using a fluorescence-based automated DNA sequencer, as previously described (19). The PCR primer sequences used for direct sequencing are listed in Table 1. The PCR products were directly sequenced on both strands using an ABI Prism 377 DNA sequencer (Perkin Elmer, CA, U.S.A.). No discrepancies were found between direct sequencing data and SNP-ITtrade mark data (data not shown).
###end p 15
###begin title 16
Statistical analysis
###end title 16
###begin p 17
###xml 331 332 329 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 745 746 743 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Descriptive characteristics are expressed as mean and standard deviation. The independent contribution of the clinical characteristics to BMD was determined using multiple linear regression analysis. Linkage disequilibrium between genotypes and significance of deviation from the Hardy-Weinberg equilibrium were analyzed by the chi2 test. Haplotypes were constructed using the E-M algorithm (Arlequin, ). The effect of single or combined genotypes on BMD was evaluated using either unpaired t-tests or one-way analyses of variance. Multiple linear regression analyses were performed to adjust for risk factors, with BMD as a dependent variable, and genotypes, age, weight and height each being independent variables. Unless indicated otherwise, p values less than 0.05 were considered significant. The SPSS 10.0 program (SPSS Inc., Chicago, IL, U.S.A.) was used for statistical procedures.
###end p 17
###begin title 18
RESULTS
###end title 18
###begin title 19
Subject characteristics
###end title 19
###begin p 20
###xml 100 101 96 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 123 124 119 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 258 259 251 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 299 300 289 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 340 341 327 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 384 385 368 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 423 424 404 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 561 562 539 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 603 604 578 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 648 649 620 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 692 693 661 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 16 28 <span type="species:ncbi:9606">participants</span>
The mean age of participants was 25.6+/-3.7 yr (range 20-34 yr). Body mass index was 22.9+/-2.8 kg/m2 (range 17.2-32.1 kg/m2). Multiple linear regression analysis showed a positive association between body weight and BMD at all anatomical sites: beta=0.275, p=0.001 at the lumbar spine; beta=0.253, p=0.001 at the femoral neck; beta=0.216, p=0.004 at the Ward's triangle; beta=0.329, p<0.001 at the trochanter; beta=0.299, p<0.001 at the femoral shaft. Age was negatively correlated with BMD at the proximal femur, with regression analysis showing beta=-0.312, p<0.001 at the femoral neck; beta=-0.349, p<0.001 at the Ward's triangle; beta=-0.192, p=0.010 at the trochanter; and beta=-0.223, p=0.003 at the femoral shaft. There was no association between BMD and height, calcium intake, smoking, alcohol consumption or exercise (data not shown).
###end p 20
###begin title 21
Genotype frequencies
###end title 21
###begin p 22
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5</italic>
###xml 95 102 95 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 393 395 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 785 787 785 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 920 921 918 919 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 930 931 928 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
The genotype distributions and allele frequencies for LRP5 gene polymorphisms are presented in Table 2. No polymorphisms of the A400V, V667M, R1036Q or A1525V type were observed. These data differ from those obtained from Caucasian subjects (19). We detected Q89R and A1330V polymorphisms, and these occurred at allelic frequencies comparable to those previously reported in Japanese studies (18). The Q89R and A1330V polymorphisms were in Hardy-Weinberg equilibrium. Because the number of subjects bearing the VV genotype of the A1330V polymorphism was so small (n=7), we compared those carrying the V allele (AV or VV) with those that did not (AA). Contradictory to the previous result suggesting that the two polymorphisms were in another linkage disequilibrium blocks in European (23), the distribution of combination genotypes indicated that the two polymorphisms were in linkage disequilibrium in our subjects (chi2=19.526, p<0.001). The haplotype frequencies were: QA, 357 (81.5%); QV, 44 (10.0%); RA, 16 (3.7%); RV, 21 (4.8%). Combined genotypes were constructed from the haplotypes and their frequencies were: QA-QA, 145 (66.2%); QA-QV, 32 (14.6%); QA-RA, 16 (7.3%); QA-RV, 19 (8.7%); QV-QV, 5 (2.3%); QV-RV, 2 (0.9%).
###end p 22
###begin title 23
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5</italic>
Association between LRP5 gene polymorphisms and BMD
###end title 23
###begin p 24
###xml 113 117 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5</italic>
###xml 216 223 216 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 377 378 377 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 389 390 389 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 675 676 675 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 732 733 732 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 742 749 742 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">Table 4</xref>
The study population data were separated into two categories on the basis of Q89R or A1330V polymorphisms in the LRP5 gene. No significant differences in any clinical parameters were observed between the two groups (Table 3). However, subjects with the QQ genotype had significantly higher BMD at the femoral neck and Ward's triangle, compared with those with the QR genotype (p=0.004 and p<0.001, respectively). Lumbar BMD was not different between the two groups. Multiple linear regression analyses were undertaken in order to adjust confounding variables such as age, weight and height. The Q89R polymorphism was significantly associated with BMD at the Ward's triangle (p=0.043), and marginally associated at the femoral neck (p=0.098) (Table 4).
###end p 24
###begin p 25
###xml 223 224 223 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 232 239 232 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 413 420 413 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 433 440 433 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">Table 4</xref>
When the study subjects were divided into two groups according to the presence of the V allele of the A1330V polymorphism, those with the V allele (AV or VV genotype) had lower body weight than those without (AA genotype) (p=0.035, Table 3). Other clinical parameters were similar between the two groups (data not shown). No differences in BMD values at any sites were noted between these two groups both before (Table 3) and after (Table 4) adjusting for confounding variables.
###end p 25
###begin p 26
We also examined effects of the combined genotypes on BMD. The subjects were divided into three groups according to the number of QA haplotypes: (QA haplotype=2)=(1, 1), (QA haplotype=1)=(1, 0), and (QA haplotype=0)=(0, 0). No associations between the combined genotypes and BMD were noted at any sites before or after adjusting for confounding variables (data not shown).
###end p 26
###begin title 27
DISCUSSION
###end title 27
###begin p 28
###xml 76 80 76 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5</italic>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 462 464 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 774 775 774 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
To our knowledge, this is the first study examining the association between LRP5 gene polymorphisms and BMD in the general population. We observed a statistically significant association between the Q89R polymorphism and BMD at Ward's triangle after adjusting for confounding variables. This association may have to be viewed with circumspection. The precision error for Ward's triangle measurement is considerably higher than for other regions of interest (24, 25). Further, the association was not noted at the lumbar spine, which has similar compositions of cortical and trabecular bone to the Ward's triangle. These suggest that the significant association may result from false positive one. However, the association was suggested at the femoral neck, albeit marginal (p=0.098). Therefore, we cannot exclude a possibility that this somewhat weak association is due to the small sample size providing insufficient statistical power to show modest but statistically significant associations.
###end p 28
###begin p 29
###xml 144 148 144 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5</italic>
###xml 159 163 159 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5</italic>
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 523 525 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 527 529 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 986 988 986 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1119 1121 1119 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
The association of the Q89R polymorphism with BMD appears to be further supported by the position at which this polymorphism is situated in the LRP5 gene. The LRP5 gene contains 23 exons and spans >100 kb (26). The LRP5 protein consists of a distinct ensemble of five structural motifs-four structures resembling a propeller with six blades containing YWTD spacer repeat domains, epidermal growth factor-like repeats, an LDL receptor-like ligand-binding domain, a single transmembrane domain, and a short cytoplasmic tail (27, 28). The Q89R polymorphism is located in exon 2 encoding the first of four propellers, while the A1330V polymorphism is in exon 18 encoding the LDL receptor-like domain. Although the precise function of each region is uncertain, the four propellers are of structural importance. It has been suggested that mutation in the first propeller region can alter the local hydrophobic environment, thus possibly affecting the interaction of LRP5 with other proteins (11). In addition, a number of mutations in this region in the LDL receptor propeller module can cause familial hypercholesterolemia (28), confirming that this domain is important for protein function. These suggest a possibility that the Q89R or related linked polymorphisms coding the region might alter LRP5 protein function and might be associated with BMD, suggesting need for further studies on functional differences of these polymorphisms in relation to bone metabolism.
###end p 29
###begin p 30
###xml 132 136 132 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5</italic>
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 390 392 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 394 396 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 451 453 451 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
In the present study we observed different genetic backgrounds between Koreans and Caucasians with respect to allele frequencies of LRP5 gene polymorphisms. The allele frequencies of the A400V, V667M, R1036Q and A1525V polymorphisms in Caucasians were 2-8% (19), whereas no such polymorphisms were found in our subjects. More importantly, the Q89R polymorphism was very rare in Caucasians (19, 29), whereas the polymorphism was prevalent in Japanese (18) and our Korean subjects. These data suggest that the Q89R polymorphism would not be a useful marker for bone mass in Caucasians.
###end p 30
###begin p 31
###xml 72 76 72 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LRP5</italic>
###xml 118 121 <span type="species:ncbi:9606">men</span>
In conclusion, we failed to demonstrate a clear association between the LRP5 polymorphism and peak bone mass in young men. However, the present study suggests that larger-scale studies on the Q89R polymorphism are needed.
###end p 31
###begin p 32
This work was supported by a grant from the Korea Health 21 R & D Project, Ministry of Health & Welfare, Republic of Korea (Project No. 01-PJ3-PG6-01GN11-0002).
###end p 32
###begin article-title 33
Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989
###end article-title 33
###begin article-title 34
Hip fractures among the elderly: factors associated with in-hospital mortality
###end article-title 34
###begin article-title 35
###xml 16 19 <span type="species:ncbi:9606">men</span>
Osteoporosis in men: a cellular endocrine perspective of an increasingly common clinical problem
###end article-title 35
###begin article-title 36
The loss of bone with age, osteoporosis, and fractures
###end article-title 36
###begin article-title 37
Peak bone mass
###end article-title 37
###begin article-title 38
Genetic control of susceptibility to osteoporosis
###end article-title 38
###begin article-title 39
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development
###end article-title 39
###begin article-title 40
###xml 116 120 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor
###end article-title 40
###begin article-title 41
###xml 18 22 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
High bone mass in mice expressing a mutant LRP5 gene
###end article-title 41
###begin article-title 42
High bone density due to a mutation in LDL-receptor-related protein 5
###end article-title 42
###begin article-title 43
A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait
###end article-title 43
###begin article-title 44
Regulation of bone formation and vision by LRP5
###end article-title 44
###begin article-title 45
###xml 82 87 <span type="species:ncbi:9606">women</span>
Torus palatinus: a new anatomical correlation with bone density in postmenopausal women
###end article-title 45
###begin article-title 46
###xml 73 81 <span type="species:ncbi:9606">patients</span>
The occurrence of torus palatinus and torus mandibularis in 2,478 dental patients
###end article-title 46
###begin article-title 47
###xml 8 13 <span type="species:ncbi:9606">women</span>
Elderly women with oral exostoses had higher bone mineral density
###end article-title 47
###begin article-title 48
Linkage of a QTL contributing to normal variation in bone mineral density to chromosome 11q12-13
###end article-title 48
###begin article-title 49
Genome screen for QTLs contributing to normal variation in bone mineral density and osteoporosis
###end article-title 49
###begin article-title 50
###xml 37 42 <span type="species:ncbi:9606">human</span>
Seven novel sequence variants in the human low density lipoprotein receptor related protein 5 (LRP5) gene
###end article-title 50
###begin article-title 51
Polymorphism analysis of LDL receptor-related protein 5 (LRP5)
###end article-title 51
###begin article-title 52
Reproducibility and validity of a semiquantitative food frequency questionnaire
###end article-title 52
###begin article-title 53
Development and validation of a semi-quantitative food frequency questionnaire to evaluate nutritional status of Korean elderly
###end article-title 53
###begin article-title 54
Characterization of 458 single nucleotide polymorphisms of disease candidate genes in the Korean population
###end article-title 54
###begin article-title 55
Haplotype structure, LD blocks, and uneven recombination within the LRP5 gene
###end article-title 55
###begin article-title 56
Bone density of the radius, spine, and proximal femur in osteoporosis
###end article-title 56
###begin article-title 57
Precision and sensitivity of dual-energy x-ray absorptiometry in spinal osteoporosis
###end article-title 57
###begin article-title 58
Cloning of a novel member of the low-density lipoprotein receptor family
###end article-title 58
###begin article-title 59
An extracellular beta-propeller module predicted in lipoprotein and scavenger receptors, tyrosine kinases, epidermal growth factor precursor, and extracellular matrix components
###end article-title 59
###begin article-title 60
Implications for familial hypercholesterolemia from the structure of the LDL receptor YWTD-EGF domain pair
###end article-title 60
###begin article-title 61
Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density
###end article-title 61
###begin p 62
Primer sequences for SNP-ITtrade mark assays and for direct sequencing within the LDL receptor-related protein 5 gene
###end p 62
###begin p 63
Genotype distribution and allele frequencies of polymorphisms of the LDL receptor-related protein 5 gene
###end p 63
###begin p 64
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 79 85 79 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
###xml 151 152 144 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 161 162 154 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
*Values represent number of times the allele was detected (% of all subjects). daggerDeviation from the Hardy-Weinberg equilibrium as determined by chi2 test. A p value >0.05 indicates the genotypes are in Hardy-Weinberg equilibrium.
###end p 64
###begin p 65
###xml 52 53 52 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Comparison of clinical characteristics and BMD (g/cm2). The study population was separated into two groups on the basis of having either the Q89R or A1330V polymorphism in the LDL receptor-related protein 5 gene
###end p 65
###begin p 66
###xml 132 133 130 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 133 134 131 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 149 155 147 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
###xml 155 156 148 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 171 184 164 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8225;</sup>
###xml 184 185 165 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
All values are mean+/-SD. Differences in clinical characteristics between the two groups were tested using unpaired t-tests, where: *p<0.005 vs. QQ; daggerp<0.001 vs. QQ; double daggerp<0.05 vs. AA.
###end p 66
###begin p 67
Multiple linear regression analysis with BMD as the dependent variable, and age, weight, height and genotypes as the independent variables
###end p 67
###begin p 68
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
*NS denotes not significant.
###end p 68

